Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: A report from the Euro Heart Survey on Diabetes and the Heart

European Heart Journal

Volumn 29, Issue 2, 2008, Pages 177-184

  Anselmino, Matteo ^a   Öhrvik, John ^b   Malmberg, Klas ^b   Standl, Eberhard ^c   Rydén, Lars ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Diabetes Research Institute   (Germany)

Author keywords

Cardiovascular endpoints; Coronary artery disease; Diabetes mellitus; Insulin; Mortality; Newly detected diabetes; Oral glucose lowering drugs

Indexed keywords

INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG TOLERABILITY; FEMALE; HEALTH SURVEY; HEART INFARCTION; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; STROKE;

AGED; BLOOD GLUCOSE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SURVEYS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; PROGNOSIS; SULFONYLUREA COMPOUNDS; SURVIVAL ANALYSIS;

EID: 38349133437     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm519     Document Type: Article

References (5)

1. Bartnik M, Rydén L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl E, Soler-Soler J, Ohrvik J. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on Diabetes and the Heart. Eur Heart J 2004;25:1880-1890.
2. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393.
3. Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care 2002;25:608-613.
4. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27(Suppl. 1):S15-S35.
5. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D. Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28:88-136.